Aurélie Mahalatchimy

Discipline

Droit (22) Sciences de l'information et de la communication (11) Sociologie (4) Science politique (1)

Type de document

Colloques et conférences (20) Articles (17) Rapports (9) Billets de blog (3) Autres (1) Livres et chapitres d'ouvrages (1)

Type de document

Livres et chapitres d'ouvrages (2)

Co-auteur

Date

Date

Source

Source

Mot-clé

Science (20) Treatment (19) thérapie (14) recherche (14) Therapeutics (14) Social sciences (14) Research (14) Research (14) Development (13) Science (13) Publics (13) Patients (12) Patients (11) gène (10) paysage (9) information (9) Stairs (9) Landscapes (9) représentation de paysage (9) science (8) Manufactures (8) Biotechnology (8) Medicine (8) projet (7) produit (7) méthodologie (7) Union européenne (7) Law and legislation (7) Methodology (7) Will (7)

Mot-clé

History (2) Boundaries (2) Possibility (2) Motion (2) Finance (2) Ethics (2) Posibilidad (2) Historia (2) Finanzas (2) Ética (2) Gaine (2) Éthique (2) Philosophie (2) Histoire (2) Transhumanisme (2) Publics (2) Limites (2) Possibilité (2) Mouvement (2) Morale (2) Finances (2) Histoire (2) Monde (2) cosmos (2) histoire (2) mouvement/immobilité (2)

Documents écrit par Aurélie Mahalatchimy (51) | parle de Aurélie Mahalatchimy (2)

Les droits fondamentaux comme frontières de la médecine améliorative de l'humain : l'application du principe d'égalité
Aurélie Mahalatchimy et al. (4 janv. 2024)
An exploratory analysis on the involvement of European organisations in the field of biomedical innovation
Anaëlle Scheer et al. (24 oct. 2023)
Comparing actors participating in the adoption process of SoHo and ATMP regulations at the European level
Valentin Brunel et al. (24 oct. 2023)
The challenges of Advanced Therapy Medicinal Products manufacturing in the European Union: Strengths and limits of current regulatory tools
Luc-Sylvain Gilbert et al. (24 oct. 2023)
Mapping regulators’ early interactions procedures to support innovation
Auxane Delage et al. (24 oct. 2023)
Innovative therapy in European Parliament's positions: a numerical science-based vocabulary analysis
Thomas Allouche et al. (24 oct. 2023)
EuroGCT, D2-2: Research community hub, a report on dissemination and uptake of information produced in WP4 via the EuroGCT online research and regulatory community hub
Aurélie Mahalatchimy et al.
EuroGCT D4-2: Resources on practical steps- a set of information resources on the practical steps needed for cell and gene therapy development
Hsin-Yu Kuo et al.
EuroGCT D4-1: Landscape mapping, report on mapping of European cell and gene therapy landscape at multiple levels
Aurélie Mahalatchimy et al.
EuroGCT Deliverable D4.7: Information collation, report on collation of existing information and links on where to seek information and guidance- Version 2.0
Hsin-Yu Kuo et al.
EuroGCT D4-2: Resources on practical steps- a set of information resources on the practical steps needed for cell and gene therapy development
Hsin-Yu Kuo et al.
EuroGCT Deliverable D4.7: Information collation, report on collation of existing information and links on where to seek information and guidance- Version 2.0
Hsin-Yu Kuo et al.
EuroGCT D4-1: Landscape mapping, report on mapping of European cell and gene therapy landscape at multiple levels
Aurélie Mahalatchimy et al.
EuroGCT, D2-2: Research community hub, a report on dissemination and uptake of information produced in WP4 via the EuroGCT online research and regulatory community hub
Aurélie Mahalatchimy et al.
Finding out the regulatory requirements for the development of Gene and Cell therapy products with the EuroGCT research pathways
Auxane Delage et al. (23 avr. 2023)
La plateforme des politiques de santé de l'Union européenne : un outil de participation civile à la construction du droit
Éloïse Gennet et al. (7 janv. 2023)
I-BioLex Deliverable D9-1: Data Management Plan version 2.0
Aurélie Mahalatchimy et al.
Bringing gene and cell therapies from lab to patients: the EuroGCT research pathways
Auxane Delage et al. (11 oct. 2022)
Improving access to innovative medicines: proposals from national authorities to revise the European legislation
Aurélie Mahalatchimy et al. (11 oct. 2022)
The new European regulation on Health Technology Assessment: what changes for Advanced Therapy Medicinal Products ?
Blanka Bartos et al. (11 oct. 2022)
Innovation for Good: a Global Technology Governance Perspective by Professor David Winickoff (OECD), 01 Jun 2022, 5:00- 6:00PM (UTC+1), Law and Technologies Webinar Series | Oxford Law Faculty
Aurélie Mahalatchimy (26 mai 2022)
Multi Scale Ethics – Why we need a sociological approach to the ethics of AI in healthcare at different scales, 8 June from 5pm-6pm (UTC+1)
Aurélie Mahalatchimy (26 mai 2022)
15th European Public Health Conference 2022: Strengthening health systems: improving population health and being prepared for the unexpected
Aurélie Mahalatchimy (26 mai 2022)
Des dispositifs médicaux au service du transhumanisme: jusqu’où doit-on aller ?
Claire Cherrier et al. (27 mai 2021)
Le sport augmenté, une révolution en marche à autoriser ?
Marine Lahaye et al. (27 mai 2021)

next
Penser l’éthique transhumaine au prisme de l’éthique humaine : enjeux et limites
Christophe Salvat (2024)
Penser l’éthique transhumaine au prisme de l’éthique humaine : enjeux et limites
Christophe Salvat (2024)